Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-24T10:58:20.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision entry v3.4.3 was added to the study record history, and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-10T02:48:31.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The record history now includes a new revision v3.4.2 and removes v3.4.1 from the history. This update affects only the history log and not the study data.
    Difference
    0.1%
    Check dated 2026-02-16T15:33:23.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.4.1) added and the previous revision (v3.4.0) removed, reflecting an update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-02-09T09:50:59.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The Record History page now shows a glossary toggle and uses green highlights for additions and red highlights for deletions, with the revision label updated from v3.3.4 to v3.4.0.
    Difference
    1%
    Check dated 2026-01-26T07:46:14.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Record History now includes a new version entry v3.3.4 and removes the v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T05:56:17.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.